U.S. researchers have created an arsenic-based chemotherapy drug using nanoparticles that attacks cancer but minimizes damage to ovarian tissue, follicles or eggs and may help protect fertility in women undergoing treatment. The team also developed a rapid toxicity test to evaluate the effect that current and new chemo drugs have on ovarian function. The findings were published in PLOS ONE.

Full Story:
Medical News Today

Related Summaries